Current challenges in CV risk reduction for high-risk primary and secondary prevention populations.
Topic:
Lipids
Sponsored by Pfizer, Inc.
Event:
ESC Congress 2016
Congress Presentation
About the speakers
Professor J Wouter Jukema
Leiden University Medical Center, Leiden (Netherlands (The))
16
presentations
0
follower
Doctor C Michael Gibson
Harvard Medical School, Boston (United States of America)
10
presentations
0
follower
3 more presentations in this session
Welcome and introductions - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.
Speaker: Doctor C. Gibson (Boston, US)
Beyond statins: understanding unmet need across the CV risk continuum.
Speaker: Professor W. Koenig (Munich, DE)
Panel discussion / Q&A - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.
Speaker: Doctor C. Gibson (Boston, US) Professor W. Koenig (Munich, DE) Professor J. Jukema (Leiden, NL)
Access the full session
Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations
Speakers:
Professor J. Jukema, Doctor C. Gibson, Doctor C. Gibson, Professor W. Koenig, Doctor C. Gibson...
About the event
ESC 365 is supported by
